Mission Bio Updates Tapestri Platform to Enable a Broader Range of Single Cell Studies in Heme-Oncology Research

SOUTH SAN FRANCISCO, Calif.: SOUTH SAN FRANCISCO, Calif., Sept. 8, 2021 /PRNewswire/ -- Mission Bio, the pioneer in high-throughput single-cell DNA and multi-omics analysis, today announced two key improvements to the core capabilities of its Tapestri Platform intended to expand its accessibility and utility in the area of hematologic oncology...

Click to view original post